T/NN
cells/NNS
from/IN
renal/JJ
cell/NN
carcinoma/NN
patients/NNS
exhibit/VBP
an/DT
abnormal/JJ
pattern/NN
of/IN
kappa/NN
B-specific/JJ
DNA-binding/JJ
activity/NN
:/:
a/DT
preliminary/JJ
report/NN
./.

Recent/JJ
data/NNS
suggest/VBP
that/IN
the/DT
poor/JJ
induction/NN
of/IN
a/DT
T-cell/NN
response/NN
to/TO
human/JJ
renal/JJ
cell/NN
carcinoma/NN
(/(
RCC/NN
)/)
may/MD
be/VB
related/JJ
to/TO
alterations/NNS
in/IN
signal/NN
transduction/NN
pathways/NNS
./.
=====
We/PRP
report/VBP
that/IN
T/NN
cells/NNS
from/IN
RCC/NN
patients/NNS
have/VBP
two/CD
alterations/NNS
in/IN
kappa/NN
B/NN
motif-specific/JJ
DNA-binding/JJ
activity/NN
./.
=====
The/DT
first/JJ
alteration/NN
involves/VBZ
the/DT
constitutive/JJ
expression/NN
of/IN
substantial/JJ
kappa/NN
B-binding/JJ
activity/NN
in/IN
nuclear/JJ
extracts/NNS
,/,
which/WDT
was/VBD
observed/VBN
in/IN
the/DT
electrophoretic/JJ
mobility/NN
shift/NN
assay/NN
./.
=====
The/DT
magnitude/NN
of/IN
kappa/NN
B/NN
activity/NN
in/IN
unstimulated/JJ
patient/NN
T/NN
cells/NNS
was/VBD
similar/JJ
to/TO
that/DT
observed/VBN
in/IN
T/NN
cells/NNS
from/IN
normal/JJ
individuals/NNS
that/WDT
had/VBD
been/VBN
activated/VBN
in/FW
vitro/FW
./.
=====
On/IN
the/DT
basis/NN
of/IN
Western/NN
blotting/NN
experiments/NNS
using/VBG
antibodies/NNS
to/TO
kappa/NN
B/Rel/NN
family/NN
proteins/NNS
,/,
the/DT
kappa/NN
B-binding/NN
activity/NN
constitutively/RB
expressed/VBN
in/IN
T/NN
cells/NNS
from/IN
RCC/NN
patients/NNS
is/VBZ
composed/VBN
mostly/RB
of/IN
the/DT
NF-kappa/NN
B1/NN
(/(
p50/NN
)/)
subunit/NN
./.
=====
The/DT
second/JJ
abnormality/NN
in/IN
kappa/NN
B-binding/JJ
activity/NN
in/IN
T/NN
cells/NNS
from/IN
these/DT
patients/NNS
is/VBZ
that/IN
RelA/NN
,/,
a/DT
member/NN
of/IN
the/DT
Rel/NN
homology/NN
family/NN
which/WDT
is/VBZ
part/NN
of/IN
the/DT
normal/JJ
NF-kappa/NN
B/NN
complex/NN
,/,
was/VBD
not/RB
induced/VBN
in/IN
the/DT
nucleus/NN
following/VBG
activation/NN
./.
=====
Western/NN
blotting/NN
analysis/NN
did/VBD
not/RB
detect/VB
any/DT
RelA/NN
in/IN
nuclear/JJ
extracts/NNS
either/CC
before/IN
or/CC
after/IN
stimulation/NN
of/IN
T/NN
cells/NNS
./.
=====
The/DT
altered/JJ
kappa/NN
B-binding/JJ
activity/NN
in/IN
T/NN
cells/NNS
from/IN
RCC/NN
patients/NNS
may/MD
impair/VB
their/PRP$
capacity/NN
to/TO
respond/VB
normally/RB
to/TO
various/JJ
stimuli/NNS
./.